Brief: Zymeworks Doses First Patient In Phase 1 Trial Of ZW191 For Folate Receptor-⍺ Positive Advanced Tumors

Zymeworks

05/11/2024 11:19

Nov 5 (Reuters) - Zymeworks Inc  ZYME.O :
    * ZYMEWORKS ANNOUNCES FIRST PATIENT DOSED IN PHASE 1
CLINICAL
TRIAL EVALUATING ZW191 IN FOLATE RECEPTOR-⍺ EXPRESSING ADVANCED
SOLID TUMORS
    * ZYMEWORKS: EXPECTS TO ENROLL PATIENTS AT INVESTIGATOR
SITES IN
NORTH AMERICA, EUROPE, AND ASIA-PACIFIC REGION

Source text:  ID:nGNE8g92MD 
Further company coverage:  ZYME.O 

 ((Reuters.Briefs@thomsonreuters.com;))